✦ LIBER ✦

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis

✍ Scribed by W. Graninger; C. Wenisch; E. Wiesinger; M. Menschik; J. Karimi; E. Presterl

Book ID: 105278001
Publisher: Springer
Year: 1995
Tongue: English
Weight: 380 KB
Volume: 14
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01690746

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duration of post-surgical antibiotic the

Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience

✍ Thierry Rod-Fleury; Nathalie Dunkel; Mathieu Assal; Peter Rohner; Phedon Tahintz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 136 KB

Cumulative Experience with High-Dose Int

Cumulative Experience with High-Dose Intravenous Cyclophosphamide and ACTH Therapy in Chronic Progressive Multiple Sclerosis

✍ JONATHAN L. CARTER; DAVID M. DAWSON; DAVID A. HAFLER; ROBERT J. FALLIS; LYNN STA 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Outpatient management with oral corticos

Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease

✍ Roger N. Danziger; Avner T. Goren; Jack Becker; Jeffrey M. Greene; Steven D. Dou 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Cognitive Remediation Therapy for outpat

Cognitive Remediation Therapy for outpatients with chronic schizophrenia: A controlled and randomized study

✍ Rafael Penadés; Rosa Catalán; Manel Salamero; Teresa Boget; Olga Puig; Joana Gua 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Experience with a physician-directed, cl

Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA

✍ A. D. Tice 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 580 KB

FDA report: Ferumoxytol for intravenous

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Feraheme™ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise